1. More details available upon request (info@synapcon.com)
SynapCon – CEO/COO Sven Engel
Personal Profile
⁻ 10 years of experience in preclinical research (pharmacology, helminthology, molecular
biology, biotechnology, Hoechst AG)
⁻ 25 years of professional experience in clinical drug development (10 years Hoechst AG and its
successor companies - of which 5 years in international marketing with responsibility Asia -
Pacific, 15 years autonomously with global project responsibility)
⁻ A strong, resilient network to professional associations (German Biotech Cluster, Dechema),
organizations (House of Pharma), patients' associations (ACHSE e.V.), specialists (in different
common and rare indications, specific needs like data management and medical writing),
strong global partner network (orphan reach).
⁻ Superior exposure to authorities in Germany, Austria and Switzerland (PEI/BfArM,
Swissmedic).
Strengths and Competencies
⁻ Strong enforcement project management, team management and team building
⁻ Special competent employees and freelancers
⁻ Extensive experience in intercultural management of complex projects
⁻ Comprehensive technical and organizational know-how
Professional Experience
⁻ Clinical operations (phase II - IV) with specialization in the field of rare diseases (studies with
small patient population)
⁻ Feasibility studies (regardless of further study continuation) with attractive fixed price levels
⁻ Recent and extensive experience with non-interventional projects (close cooperation with
marketing and sales departments).
⁻ Regulatory (authorities, ethics) and negotiation (preparation) of contracts with institutions
(contracts with investigators)
Selected references
⁻ Lantus (Insulin)
⁻ Exubera (Inhalative Insulin)
⁻ Ketek (Antibiotic)
⁻ Firazyr (Icatibant – Bradikininantagonist)
⁻ Cefrome (Antibiotics)
⁻ Propentofylline (Dementia, Alzheimer and Vascular)
⁻ Amielderly (Psychoses)
⁻ Femara (Breast cancer)
⁻ Dermatology (Psoriasis, Skin atrophy, Mycosis)
⁻ Adipositas, Cardiovascular diseases
⁻ Hematologic disorders (e.g. Afibrinogenaemia, Neutropenia)
⁻ Further rare diseases (HAE, lysosomal storage disorders)
⁻ Paediatrics and neonatology